Patricia S. Meisner, CEO and Co-Founder
Patricia brings 25 years of executive operating experience from both early stage and mature companies in the medical device, diagnostics, life science companies, including Invitrogen, T Cell Sciences and Sigma Aldrich Corporation. She has brought multiple new products to market in the areas of HIV monitoring; cancer diagnostics, pharmaceutical drug discovery. Prior to founding ActualMeds , Patricia founded RedTail Solutions, a Software as a Service (SaaS) company serving middle-market manufacturers in the global supply chain. While serving as its CEO (2000-2008), she established a new revenue and business model in this segment and built a capital-efficient business that achieved profitability in 2007. Patricia holds a B.A. degree in Biology from Kenyon College, an M.S. in Biochemistry and an M.B.A. from Case Western Reserve University.
Anne Marie Biernacki, CTO and Co-Founder
CTO and Co-Founder Anne Marie Biernacki has prior experience in today’s rapidly evolving e-health sector, as well as being a successful technology and operations executive and career entrepreneur with over 18 years of diverse experience in developing innovative systems. Among other ventures, she was part of the founding team of an early e-health company acquired by Web MD, and had a successful exit with consumer technology company Digiticians, which she co-founded and self- funded. She is skilled in the development of platforms and operations for the Web 2.0 environment and at integrating business drivers and technology solutions, especially rules-based systems.
Previously, she was Executive Vice President/ Chief Informatics Systems Officer at IC Sciences. Anne Marie holds a B.S. degree in Electrical Engineering from the University of Dayton and an M.S. in EE from Tufts University. She was a Draper Fellow at the Charles Stark Draper Laboratory.
Patricia J Neafsey, Principal Scientist and Co-Founder
Patricia J. Neafsey, RD, PhD is a pharmacologist, registered dietitian and professor in the Center for Health Intervention and Prevention (CHIP) and the School of Nursing at the University of Connecticut. She has undergraduate and master’s degrees in nutritional biochemistry from Cornell University and a doctorate in pharmaceutical science from the University of Connecticut. She received her post-doctoral training at Tufts University. She is an author on over 100 peer reviewed publications and was the principal investigator on grants (totaling over 1.3 million from the University of Connecticut Research Foundation, the Donaghue Medical Research Foundation, and the NIH National Heart Lung and Blood Institute) that funded the development and testing of a computer-based intervention to improve patient adherence to antihypertensive regimens and reduce adverse self-medication behaviors. The International Medical Informatics Society gave her research team a “Best of Medical Informatics” citation in 2003.
Joseph Gruber, Chief Pharmacy Officer
Joseph Gruber, RPH, CGP, FASCP is a former Chief Executive Officer of ASCP Ventures, Inc., VP Clinical Products with Mirixa Corporation and has over 20 years’ experience in the long-term care setting. He is a graduate of the St. Louis College of Pharmacy, received his Masters’ Certification in Gerontology from Southern Illinois University, and holds his Board Certification in Geriatric Pharmacy. Joseph is Past President and Chair of the American Society of Consultant Pharmacists and currently serves on the ASCP Council of Presidents. Joseph has given numerous presentations on geriatric pharmacotherapy, gero-psychiatric pharmaceutical care, quality indicators, health management and medication therapy management services, is a contributor to ASCP poster presentations and The Consultant Pharmacist journal, has participated in consensus panels and publications, and is the inaugural 2001 recipient of the CCGP/AstraZeneca Excellence in Geriatric Pharmacy Practice Award.
Mark has been involved in healthcare innovation and transformation for his entire career, initially with CIGNA where Mark worked with the company’s largest clients on creative funding approaches and benefit design. While at CIGNA, Mark served on the Sales & Marketing Advisory Council for 20 consecutive years, and worked closely with the executive leadership team on a broad range of strategic initiatives. After Cigna, Mark served as a member of the original executive team at ActiveHealth Management, a leading clinical decision support technology provider, which was ultimately acquired by Aetna. He was actively involved in market analysis, product development, and M&A. Mark has spent the last several years working with large employers, healthcare companies and early stage technology companies assisting with creative go-to-market strategies, sales and relationship management. He has worked as a consultant to private equity and venture capital investors, assisting with pre-acquisition due diligence and currently serves as a member of the OptumHealth Consultant Advisory Board. Mark has a BS in Economics from Trinity College in Hartford, CT.